ARCHIVES

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

This article is from The Cancer Letter archive.

Vol. 33 No. 15 | April 20, 2007

Download PDF Visit The Full Archive

Related Articles

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002

NCI Pilot to Speed Phase III Trials Deemed Unsuccessful, Will Be Shut Down

November 22, 2002

Nobelist Offer “Electronic” Theory Of Cancer

June 27, 1975

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

March 16, 2007

National Cancer Act: Early Promises Were Overstated

May 15, 1998

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011